Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine for Alleviating Symptoms Caused by Lugol Chromoendoscopy
NCT04764643Completed
- Sponsor
- Xijing Hospital of Digestive Diseases
- Start
- Feb 2020
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of acetylcysteine in esophagitis (2 arms), sponsored by Xijing Hospital of Digestive Diseases. Primary endpoint: Mean Visual Analogue Scale Change at 30 minutes. Started Feb 2020; status: completed.
02
Drugs
acetylcysteine
03
Conditions
esophagitis
Beyond the preview
Go deeper on NCT04764643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04764643.